# 5. Discussion

The project has moved beyond a simple dashboard into an auditable research workflow.

The most important progress is the addition of exact small-instance validation. This gives the project a ground-truth layer for small QUBO instances before interpreting heuristic, quantum, or compression outputs.

The graph-aware QRAO phase also strengthens the compression direction. Instead of only estimating qubit savings by dividing variables into smaller counts, the project now uses the QUBO interaction graph to avoid placing interacting variables on the same compressed qubit.

This is important because compression should not be treated as a simple variable-count reduction. It must be evaluated as a relaxation that requires mapping, rounding, feasibility checks, and comparison against exact or best-known solutions.

The biological validation side is still being expanded. Phase 45 added dataset tracking and external-validation planning, but RNAfold/ViennaRNA, BLAST, and RCSB results still need to be manually collected and verified before biological claims are made.
